0 results available. Select is focused ,type to refine list, press Down to open the menu,
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. The company’s portfolio includes Jornay PM, a cen...
The following section summarizes insights on Collegium Pharmaceutical Inc's Price Close (Div & Split Adjusted):
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Price Close (Div & Split Adjusted) in the valuation category include:
The price at the close of the last trading day. Price history is adjusted for stock splits and dividends, as applicable.
The chart above depicts the distribution of price close (div & split adjusted) for companies operating in the Healthcare sector in the Developed economic region. Over 3,140 companies were considered in this analysis, and 3,085 had meaningful values. The average price close (div & split adjusted) of companies in the sector is 8.17 with a standard deviation of 21.37.
Collegium Pharmaceutical Inc's Price Close (Div & Split Adjusted) of 29.39 ranks in the 92.0% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 3,148 |
| Included Constituents | 3,085 |
| Min | 0.00 |
| Max | 171.24 |
| Median | 0.83 |
| Mean | 8.17 |
| Standard Deviation | 21.37 |
You can find companies with similar price close (div & split adjusted) using this stock screener.